Cancer forms a large part of urological practice. Prostate cancer
is the most significant and is the second most common cause of male
cancer deaths with some 300,000 cases in the USA annually. Cancer
of the bladder is also common. While treatment has been primarily
surgical, recent years have seen an explosion of new drug therapies
for urological cancers.
All urologists, whether in training or in practice, need an
up-to-date survey of the literature and key findings in this
important and controversial field.
This book takes each organ in turn (prostate, kidney, bladder,
testis and penis) and tackles the controversies head-on by inviting
chapters on various (often rival) treatments for each disease. Each
section is then concluded by a commentary from the editor which
draws together the various strands, outlines the principal areas of
consensus and disagreement.
Jonathan Waxman is an oncologist who specialises in urological
tumours and has developed new treatments for prostate, bladder and
kidney cancer and for terminal care, which are now part of standard
practice. He founded the Prostate Cancer Charity and helped
establish an all-party parliamentary group to improve cancer
treatment and research throughout the UK.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!